Bacterial Infections in Poultry: Clinical Manifestations, Diagnosis, and Antimicrobial Therapy
Introduction
Bacterial infections represent a significant cause of morbidity, mortality, and economic loss in commercial poultry operations worldwide. The intensive housing conditions typical of modern broiler, layer, and breeder facilities facilitate the rapid transmission of bacterial pathogens. These infections manifest across a spectrum of clinical presentations, from acute septicemic disease to chronic, subclinical conditions that impair growth performance and egg production. This article provides a detailed examination of four major bacterial disease complexes in poultry: colibacillosis, fowl cholera, necrotic enteritis, and mycoplasmosis. For each condition, the clinical manifestations, pathological findings, diagnostic approaches, and antimicrobial therapy protocols are discussed, with particular emphasis on antimicrobial resistance trends and stewardship.
Colibacillosis
Etiology and Pathogenesis
Colibacillosis is caused by avian pathogenic Escherichia coli (APEC), a subset of extraintestinal pathogenic E. coli that possess specific virulence factors enabling colonization and invasion of the avian host. APEC strains typically harbor large plasmids encoding genes for adhesins (e.g., type 1 fimbriae, P fimbriae), iron acquisition systems (e.g., aerobactin, salmochelin), and toxins (e.g., hemolysin, cytotoxic necrotizing factor). The pathogenesis begins with inhalation or ingestion of the organism, followed by colonization of the respiratory epithelium. In immunocompromised birds or those with concurrent viral infections (e.g., infectious bronchitis virus, Newcastle disease virus), APEC can breach mucosal barriers and enter the bloodstream, leading to septicemia.
Clinical Manifestations
The clinical presentation of colibacillosis varies with the age of the bird and the route of infection. In young chicks, acute septicemia is common, characterized by depression, ruffled feathers, reduced feed intake, and increased mortality. In older birds, respiratory signs including rales, coughing, and dyspnea may predominate, often secondary to environmental stressors or viral respiratory infections. Chronic forms of the disease include airsacculitis, pericarditis, perihepatitis, and salpingitis in laying hens. Egg peritonitis, characterized by the presence of yolk material in the abdominal cavity, is a frequent finding in layer flocks.
Necropsy Findings
Gross pathological lesions in colibacillosis are highly characteristic. The hallmark lesion is fibrinous polyserositis, with a thick, yellow, fibrinous exudate covering the heart (pericarditis), liver (perihepatitis), and air sacs (airsacculitis). The pericardial sac is often distended with fibrin and serous fluid. The liver may be enlarged, congested, and covered with a fibrinous membrane. In cases of salpingitis, the oviduct is distended with caseous, yellow exudate. Yolk peritonitis presents as a diffuse, fibrinous inflammation of the peritoneal surfaces with free yolk material in the abdominal cavity.
Diagnosis
Definitive diagnosis of colibacillosis requires isolation and identification of E. coli from affected tissues. Samples for culture should be collected aseptically from liver, spleen, heart blood, or bone marrow. Standard bacteriological culture on MacConkey agar yields lactose-fermenting colonies after 18-24 hours of aerobic incubation at 37 degrees Celsius. Biochemical confirmation is performed using commercial identification systems or automated biochemical panels. Serotyping of O antigens (e.g., O1, O2, O78) is useful for epidemiological tracking but is not routinely performed in diagnostic laboratories. Molecular methods, including polymerase chain reaction (PCR) targeting virulence-associated genes (e.g., iroN, iss, iucD), can differentiate APEC from commensal E. coli strains. For a detailed discussion of APEC virulence factors and rapid diagnostic assays, refer to the article on Avian Pathogenic Escherichia coli (APEC): Virulence Factors, Rapid Diagnostic Assays, and Biosecurity Strategies.
Antimicrobial Therapy
Antimicrobial therapy for colibacillosis is guided by culture and susceptibility testing due to the high prevalence of multidrug resistance in APEC isolates. Commonly used antimicrobial classes include penicillins (amoxicillin), aminoglycosides (gentamicin, spectinomycin), fluoroquinolones (enrofloxacin), phenicols (florfenicol), and tetracyclines (oxytetracycline, chlortetracycline). Withdrawal periods vary by drug and jurisdiction; for example, enrofloxacin typically requires a 7-10 day withdrawal period for meat and a 7-14 day period for eggs in many regulatory frameworks. Resistance to tetracyclines and sulfonamides is widespread, and fluoroquinolone resistance is an emerging concern. The use of critically important antimicrobials for human medicine, such as third-generation cephalosporins and fluoroquinolones, should be reserved for cases where susceptibility testing confirms their necessity.
Fowl Cholera
Etiology and Pathogenesis
Fowl cholera is a contagious disease of domestic and wild birds caused by Pasteurella multocida. Multiple serotypes exist, with serotypes A:1, A:3, and A:4 being most commonly associated with disease in poultry. The organism is a Gram-negative, bipolar-staining coccobacillus. Pathogenesis involves inhalation or ingestion of the bacterium, followed by colonization of the upper respiratory tract. Virulence factors include a polysaccharide capsule that inhibits phagocytosis, lipopolysaccharide endotoxin, and outer membrane proteins. The organism can rapidly invade the bloodstream, causing acute septicemia and death.
Clinical Manifestations
Fowl cholera presents in peracute, acute, and chronic forms. In peracute cases, birds are found dead with no premonitory signs. Acute disease is characterized by fever, depression, anorexia, mucoid discharge from the mouth and nares, cyanosis of the comb and wattles, and diarrhea. Mortality can reach 50% in untreated flocks. Chronic fowl cholera typically involves localized infections, including swollen wattles (wattle edema), conjunctivitis, sinusitis, and arthritis. Lame birds with swollen hock joints are a common presentation in chronic cases.
Necropsy Findings
Peracute cases may show few gross lesions other than generalized congestion. Acute cases present with petechial hemorrhages on the epicardium, serosal surfaces, and abdominal fat. The liver is often enlarged, friable, and studded with multiple small, pale foci of necrosis (miliary necrosis). The spleen is enlarged and congested. Pneumonia and airsacculitis may be present. Chronic cases show caseous abscesses in the wattles, sinuses, and joints. For a broader discussion of serotypes and outbreak dynamics in wild and domestic birds, see the article on Avian Cholera in Waterfowl: Pasteurella multocida Serotypes, Outbreak Dynamics, and Vaccination Approaches in Wild and Domestic Birds.
Diagnosis
Presumptive diagnosis is based on clinical signs and gross pathology. Confirmation requires isolation of P. multocida from blood, liver, spleen, or bone marrow. The organism grows on blood agar as small, gray, mucoid colonies with a characteristic "mousy" odor. It is oxidase-positive, catalase-positive, and indole-positive. Bipolar staining with Wright's or Giemsa stain is a useful rapid diagnostic feature. Molecular confirmation via PCR targeting the P. multocida-specific gene kmt1 is available. Serotyping is performed using the Heddleston scheme for epidemiological purposes.
Antimicrobial Therapy
P. multocida is generally susceptible to a range of antimicrobials, but resistance has been reported. Effective drugs include penicillin, ampicillin, oxytetracycline, chlortetracycline, florfenicol, and enrofloxacin. Sulfonamides and trimethoprim-sulfonamide combinations are also effective. Treatment should be administered in the drinking water for 3-5 days. In severe outbreaks, individual bird therapy with injectable oxytetracycline or penicillin may be warranted. Withdrawal periods for meat and eggs must be observed. Vaccination with inactivated bacterins or live attenuated vaccines is used for prevention in endemic areas.
Necrotic Enteritis
Etiology and Pathogenesis
Necrotic enteritis is an enteric disease of broiler chickens caused by Clostridium perfringens, primarily type A and, less commonly, type C. The disease is toxin-mediated, with the NetB toxin (for type A strains) and alpha toxin playing central roles in pathogenesis. Predisposing factors include coccidial infection (particularly Eimeria maxima or E. acervulina), dietary changes (high levels of wheat, barley, or rye), and immunosuppression. The pathogenesis involves disruption of the intestinal mucosa by coccidia or dietary factors, allowing C. perfringens to proliferate and produce toxins that cause coagulative necrosis of the intestinal epithelium.
Clinical Manifestations
Necrotic enteritis occurs in clinical and subclinical forms. Clinical disease typically affects broilers between 2 and 6 weeks of age. Affected birds are depressed, anorexic, and have ruffled feathers. Diarrhea is common, often with a dark, tarry appearance. Mortality can reach 10-30% in untreated flocks. The subclinical form is characterized by reduced growth rates, poor feed conversion, and focal necrosis of the intestinal mucosa without overt clinical signs.
Necropsy Findings
Gross lesions are confined to the small intestine, particularly the jejunum and ileum. The intestinal wall is thin, friable, and distended with gas and fluid. The mucosa is covered with a characteristic "Turkish towel" appearance: a thick, yellow-brown, fibrinous pseudomembrane that is easily detached. The intestinal contents are often dark and watery. The liver may be congested but is typically not involved. In chronic cases, focal mucosal ulcers may be present.
Diagnosis
Diagnosis is based on clinical signs, gross pathology, and histopathology. Impression smears of the intestinal mucosa stained with Gram stain reveal large, Gram-positive, rod-shaped bacteria. Anaerobic culture of intestinal contents or mucosal scrapings on blood agar or tryptose sulfite cycloserine (TSC) agar yields C. perfringens. Quantitative culture is important, as C. perfringens is a normal inhabitant of the avian gut. Counts exceeding 10^7 colony-forming units per gram of intestinal content are considered diagnostic. PCR detection of the netB gene confirms the presence of virulent type A strains. For a comprehensive review of virulence factors and control strategies, refer to the article on Necrotic Enteritis in Broiler Chickens: Clostridium perfringens Virulence Factors, Gut Microbiome, and Probiotic Control Strategies.
Antimicrobial Therapy
Treatment of clinical necrotic enteritis involves the administration of antimicrobials effective against C. perfringens. Bacitracin methylene disalicylate (BMD) is commonly used in feed at 50-100 g/ton. Other effective drugs include lincomycin, tylosin, virginiamycin, and amoxicillin. These are typically administered in the drinking water for 3-5 days. Withdrawal periods for bacitracin are generally short (0 days for some formulations), while lincomycin and tylosin require 0-2 days withdrawal for meat. Due to concerns about antimicrobial resistance and consumer demand for antibiotic-free production, alternative control strategies are increasingly employed. These include the use of probiotics, prebiotics, organic acids, and enzymes. Coccidiosis control through vaccination or anticoccidial drugs is a critical component of necrotic enteritis prevention.
Mycoplasmosis
Etiology and Pathogenesis
Mycoplasmosis in poultry is primarily caused by Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS). These are cell wall-deficient bacteria belonging to the class Mollicutes. MG is a major respiratory pathogen, while MS causes respiratory disease and synovitis. The organisms colonize the respiratory epithelium, where they attach via specialized tip organelles and adhesin proteins (e.g., GapA, CrmA for MG). This attachment disrupts ciliary function, leading to mucociliary stasis and secondary bacterial infections. MG and MS are transmitted vertically through the egg and horizontally via aerosol and direct contact.
Clinical Manifestations
MG infection in chickens presents as chronic respiratory disease (CRD), characterized by rales, coughing, sneezing, nasal discharge, and conjunctivitis. In turkeys, MG causes infectious sinusitis, with pronounced swelling of the infraorbital sinuses. Morbidity is high, but mortality is typically low unless exacerbated by secondary infections. MS infection causes respiratory signs similar to MG but also leads to infectious synovitis, characterized by lameness, swollen joints (hock, stifle), and breast blisters. In laying hens, both MG and MS can cause a drop in egg production.
Necropsy Findings
In MG-infected birds, gross lesions include catarrhal to fibrinous airsacculitis, pericarditis, and perihepatitis. The tracheal mucosa is thickened and congested, with excess mucus. In turkeys, the infraorbital sinuses are distended with caseous or mucoid exudate. MS infection produces similar respiratory lesions plus synovitis, with the joint capsules containing a viscous, yellow-brown exudate. The tendon sheaths may be thickened and edematous.
Diagnosis
Diagnosis of mycoplasmosis relies on a combination of serology, culture, and molecular methods. Serological tests include the rapid serum agglutination (RSA) test, hemagglutination inhibition (HI) test, and commercial ELISA kits. The RSA test is a useful screening tool but has lower specificity. The HI test is more specific and is used for confirmation. ELISA kits offer high throughput and are suitable for flock-level surveillance. Culture of MG and MS requires specialized media (e.g., Frey's medium) and is slow, taking 7-21 days. PCR is the preferred method for rapid detection and species identification. Real-time PCR assays targeting the mgc2 gene for MG and the vlhA gene for MS are highly sensitive and specific. For a detailed discussion of molecular diagnostic approaches for MG, see the article on Mycoplasma gallisepticum in Backyard Poultry: Clinical Presentation and Molecular Diagnostic Approaches.
Antimicrobial Therapy
Antimicrobial therapy for mycoplasmosis is challenging due to the lack of a cell wall, which renders beta-lactam antibiotics ineffective. Effective drugs include macrolides (tylosin, tilmicosin, tylvalosin), lincosamides (lincomycin), tetracyclines (chlortetracycline, oxytetracycline), fluoroquinolones (enrofloxacin), and pleuromutilins (tiamulin). Tylosin is commonly administered in the drinking water at 500 mg/L for 3-5 days. Chlortetracycline is used in feed at 200-400 g/ton. Tiamulin is highly effective but must not be used concurrently with ionophore anticoccidials (e.g., monensin, salinomycin) due to the risk of severe toxicity. Withdrawal periods vary: tylosin typically requires 1-2 days for meat, while enrofloxacin requires 7-10 days. Eradication programs for MG and MS in breeder flocks rely on testing and culling of positive birds, combined with strict biosecurity and antimicrobial therapy.
Diagnostic Workflow
The following Mermaid diagram illustrates a generalized diagnostic workflow for bacterial infections in poultry.
flowchart TD
A[Clinical Signs Observed], > B{Postmortem Examination}
B, > C[Gross Lesions Present]
B, > D[No Gross Lesions]
C, > E[Sample Collection: Liver, Spleen, Heart Blood, Intestine, Joint Fluid]
D, > E
E, > F[Gram Stain / Direct Smear]
F, > G[Preliminary Etiologic Classification]
G, > H[Culture: Aerobic and Anaerobic]
H, > I[Isolation and Identification]
I, > J[Biochemical Confirmation / MALDI-TOF]
J, > K[Antimicrobial Susceptibility Testing]
K, > L[Targeted Antimicrobial Therapy]
I, > M[Molecular Confirmation: PCR / Real-Time PCR]
M, > N[Virulence Gene Detection / Serotyping]
N, > O[Epidemiological Tracking]
L, > P[Clinical Response Monitoring]
P, > Q[Therapy Adjustment if Needed]
Antimicrobial Resistance Considerations
Antimicrobial resistance (AMR) in poultry bacterial pathogens is a growing concern. APEC isolates frequently exhibit resistance to multiple drug classes, including tetracyclines, sulfonamides, and aminoglycosides. Extended-spectrum beta-lactamase (ESBL) production and plasmid-mediated quinolone resistance have been reported. In C. perfringens, resistance to bacitracin and lincomycin has been documented, though prevalence remains low. P. multocida has shown increasing resistance to tetracyclines and sulfonamides in some regions. Mycoplasmas can develop resistance to macrolides and fluoroquinolones through mutations in target genes (e.g., 23S rRNA, gyrA). Prudent antimicrobial use, including culture-guided therapy, adherence to withdrawal periods, and implementation of biosecurity and vaccination programs, is essential to preserve the efficacy of available antimicrobials.
Conclusion
Bacterial infections in poultry represent a complex and economically significant challenge. Colibacillosis, fowl cholera, necrotic enteritis, and mycoplasmosis each have distinct etiologies, clinical presentations, and pathological features. Accurate diagnosis requires a combination of clinical observation, necropsy, and laboratory methods including culture, serology, and molecular techniques. Antimicrobial therapy must be guided by susceptibility testing and administered with strict adherence to withdrawal periods. The emergence of antimicrobial resistance underscores the need for integrated control strategies that include vaccination, biosecurity, and alternative interventions such as probiotics and organic acids.
References
- Barnes HJ, Vaillancourt JP, Gross WB. Colibacillosis. In: Saif YM, editor. Diseases of Poultry. 12th ed. Ames: Blackwell Publishing; 2008. p. 691-732.
- Glisson JR, Hofacre CL, Christensen JP. Fowl Cholera. In: Saif YM, editor. Diseases of Poultry. 12th ed. Ames: Blackwell Publishing; 2008. p. 739-758.
- Cooper KK, Songer JG. Necrotic enteritis in chickens: a paradigm of enteric infection by Clostridium perfringens type A. Anaerobe. 2009;15(1-2):55-60.
- Ley DH, Yoder HW. Mycoplasmosis. In: Saif YM, editor. Diseases of Poultry. 12th ed. Ames: Blackwell Publishing; 2008. p. 807-864.
- Gyles CL. Antimicrobial resistance in selected bacteria from poultry. Anim Health Res Rev. 2008;9(2):149-158.
- Keyburn AL, Boyce JD, Vaz P, Bannam TL, Ford ME, Parker D, et al. NetB, a new toxin that is associated with avian necrotic enteritis caused by Clostridium perfringens. PLoS Pathog. 2008;4(2):e26.
- Kleven SH. Mycoplasma synoviae infection. In: Saif YM, editor. Diseases of Poultry. 12th ed. Ames: Blackwell Publishing; 2008. p. 845-856.
- Nolan LK, Barnes HJ, Vaillancourt JP, Abdul-Aziz T, Logue CM. Colibacillosis. In: Swayne DE, editor. Diseases of Poultry. 13th ed. Ames: Wiley-Blackwell; 2013. p. 751-805.